RU2019110980A - Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением - Google Patents
Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением Download PDFInfo
- Publication number
- RU2019110980A RU2019110980A RU2019110980A RU2019110980A RU2019110980A RU 2019110980 A RU2019110980 A RU 2019110980A RU 2019110980 A RU2019110980 A RU 2019110980A RU 2019110980 A RU2019110980 A RU 2019110980A RU 2019110980 A RU2019110980 A RU 2019110980A
- Authority
- RU
- Russia
- Prior art keywords
- hepc
- pharmaceutical composition
- methods
- application
- free acid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 9
- 208000006673 asthma Diseases 0.000 title claims 2
- 208000019693 Lung disease Diseases 0.000 title 1
- 239000002253 acid Substances 0.000 claims 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461926052P | 2014-01-10 | 2014-01-10 | |
| US61/926,052 | 2014-01-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016132762A Division RU2685706C2 (ru) | 2014-01-10 | 2015-01-12 | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2019110980A true RU2019110980A (ru) | 2019-08-26 |
Family
ID=53520398
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019110980A RU2019110980A (ru) | 2014-01-10 | 2015-01-12 | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением |
| RU2016132762A RU2685706C2 (ru) | 2014-01-10 | 2015-01-12 | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016132762A RU2685706C2 (ru) | 2014-01-10 | 2015-01-12 | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20150196521A1 (enExample) |
| EP (1) | EP3091959A4 (enExample) |
| JP (2) | JP2017505809A (enExample) |
| KR (1) | KR20160132372A (enExample) |
| CN (1) | CN106029051A (enExample) |
| AU (1) | AU2015204531B2 (enExample) |
| BR (1) | BR112016015997A2 (enExample) |
| CA (1) | CA2935986A1 (enExample) |
| IL (1) | IL246623A0 (enExample) |
| MX (1) | MX2016008953A (enExample) |
| PH (1) | PH12016501371A1 (enExample) |
| RU (2) | RU2019110980A (enExample) |
| SG (2) | SG10202000496XA (enExample) |
| WO (1) | WO2015106215A2 (enExample) |
| ZA (1) | ZA201605492B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110478342A (zh) | 2012-05-10 | 2019-11-22 | 索卢泰克斯Na有限责任公司 | 含有天然专门促消退介质及其前体的具有抗炎活性的油 |
| EP3068757B1 (en) | 2013-11-15 | 2019-02-27 | DS Biopharma Limited | Lysine salt of 15-hydroxy-8(z),11(z),13(e)-eicosatrienoic acid |
| JP2018502163A (ja) * | 2015-01-16 | 2018-01-25 | アフィミューン リミテッド | １５−ｈｅｐｅを含む組成物及びそれを使用する方法 |
| JP2018520197A (ja) * | 2015-07-21 | 2018-07-26 | アフィミューン リミテッド | 癌及び神経疾患の治療または予防において使用するための、１５−ｈｅｐｅを含む組成物 |
| WO2017041094A1 (en) | 2015-09-03 | 2017-03-09 | Solutex Na Llc | Compositions comprising omega-3 fatty acids, 17-hdha and 18- hepe and methods of using same |
| CN113230244A (zh) | 2015-12-18 | 2021-08-10 | 艾菲穆恩有限公司 | 包含15-hepe的组合物及其使用方法 |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
| CN111481550A (zh) * | 2020-05-14 | 2020-08-04 | 王兆霖 | 含有噻托溴铵和阿福特罗的药物制剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05186342A (ja) * | 1992-01-10 | 1993-07-27 | Fujirebio Inc | 免疫調節作用を併せもつ抗炎症剤 |
| IL151299A0 (en) * | 2000-02-16 | 2003-04-10 | Brigham & Womens Hospital | Aspirin-triggered lipid mediators |
| US20020188024A1 (en) * | 2000-08-23 | 2002-12-12 | Chilton Floyd H. | Fatty acid-containing emulsion with increased bioavailability |
| US20060160095A1 (en) * | 2002-12-13 | 2006-07-20 | Eirx Therapeutics Limited | Survivin |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| ES2570332T3 (es) * | 2005-03-16 | 2016-05-17 | Meda Pharma Gmbh & Co Kg | La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias |
| WO2012023254A1 (ja) * | 2010-08-19 | 2012-02-23 | 国立大学法人 東京大学 | オメガ３系脂肪酸由来の新規抗炎症性代謝物 |
| WO2012135032A2 (en) * | 2011-03-25 | 2012-10-04 | The Brigham And Women's Hospital, Inc. | Anti-inflammatory particles |
| US8293790B2 (en) * | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| US20120264705A1 (en) * | 2012-01-26 | 2012-10-18 | Dignity Sciences Limited | Antimicrobial compositions comprising 15-hetre and methods of use thereof |
| US20130267598A1 (en) * | 2012-02-23 | 2013-10-10 | Dignity Sciences Limited | Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same |
| CN110478342A (zh) * | 2012-05-10 | 2019-11-22 | 索卢泰克斯Na有限责任公司 | 含有天然专门促消退介质及其前体的具有抗炎活性的油 |
| GB201301626D0 (en) * | 2013-01-30 | 2013-03-13 | Dignity Sciences Ltd | Composition comprising 15-OHEPA and methods of using the same |
| MA41120A (fr) * | 2014-12-02 | 2017-10-10 | Afimmune Ltd | Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci |
-
2015
- 2015-01-12 MX MX2016008953A patent/MX2016008953A/es unknown
- 2015-01-12 CA CA2935986A patent/CA2935986A1/en not_active Abandoned
- 2015-01-12 AU AU2015204531A patent/AU2015204531B2/en not_active Ceased
- 2015-01-12 JP JP2016563894A patent/JP2017505809A/ja not_active Ceased
- 2015-01-12 RU RU2019110980A patent/RU2019110980A/ru unknown
- 2015-01-12 SG SG10202000496XA patent/SG10202000496XA/en unknown
- 2015-01-12 RU RU2016132762A patent/RU2685706C2/ru not_active IP Right Cessation
- 2015-01-12 BR BR112016015997A patent/BR112016015997A2/pt not_active Application Discontinuation
- 2015-01-12 CN CN201580008336.5A patent/CN106029051A/zh active Pending
- 2015-01-12 EP EP15735225.3A patent/EP3091959A4/en not_active Withdrawn
- 2015-01-12 KR KR1020167021684A patent/KR20160132372A/ko not_active Withdrawn
- 2015-01-12 SG SG11201605601UA patent/SG11201605601UA/en unknown
- 2015-01-12 WO PCT/US2015/011054 patent/WO2015106215A2/en not_active Ceased
- 2015-01-12 US US14/595,015 patent/US20150196521A1/en not_active Abandoned
-
2016
- 2016-07-06 IL IL246623A patent/IL246623A0/en unknown
- 2016-07-11 PH PH12016501371A patent/PH12016501371A1/en unknown
- 2016-07-22 US US15/217,008 patent/US20160324820A1/en not_active Abandoned
- 2016-08-08 ZA ZA2016/05492A patent/ZA201605492B/en unknown
-
2019
- 2019-08-15 JP JP2019149177A patent/JP2020002150A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015106215A3 (en) | 2016-02-18 |
| RU2685706C2 (ru) | 2019-04-23 |
| ZA201605492B (en) | 2018-11-28 |
| US20160324820A1 (en) | 2016-11-10 |
| EP3091959A4 (en) | 2017-09-20 |
| WO2015106215A2 (en) | 2015-07-16 |
| AU2015204531B2 (en) | 2019-11-14 |
| RU2016132762A (ru) | 2018-02-16 |
| CA2935986A1 (en) | 2015-07-16 |
| SG10202000496XA (en) | 2020-03-30 |
| CN106029051A (zh) | 2016-10-12 |
| JP2017505809A (ja) | 2017-02-23 |
| EP3091959A2 (en) | 2016-11-16 |
| RU2016132762A3 (enExample) | 2018-09-20 |
| SG11201605601UA (en) | 2016-08-30 |
| IL246623A0 (en) | 2016-08-31 |
| MX2016008953A (es) | 2017-02-02 |
| US20150196521A1 (en) | 2015-07-16 |
| JP2020002150A (ja) | 2020-01-09 |
| AU2015204531A1 (en) | 2016-08-18 |
| BR112016015997A2 (pt) | 2018-03-27 |
| KR20160132372A (ko) | 2016-11-18 |
| PH12016501371A1 (en) | 2016-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| CY1120049T1 (el) | (2s)-ν-[(1s)-1-κυανο-2-φαινυλαιθυλ]-1,4-οξαζεπαν-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης i | |
| RU2018136872A (ru) | Композиции, содержащие 15-oh эпк, и способы их применения | |
| EA201590251A1 (ru) | Новые 5-аминотетрагидрохинолин-2-карбоновые кислоты и их применение | |
| SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
| EA201491329A1 (ru) | 4,4-дизамещенные 1,4-дигидропиримидины и их применение в качестве лекарственных препаратов для лечения гепатита b | |
| EA201491028A1 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
| MX386256B (es) | Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos. | |
| JP2016510326A5 (enExample) | ||
| JP2016511753A5 (enExample) | ||
| RU2016145066A (ru) | Композиция для предотвращения или лечения жировых болезней печени | |
| EA201591704A1 (ru) | Новые устойчивые соли пентадекапептида, способ их получения, их применение в производстве фармацевтических составов и их применение в терапии | |
| EA202090164A1 (ru) | Изотретиноиновые перорально-слизистые композиции и способы их применения | |
| PH12015502717B1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| JP2017517574A5 (enExample) | ||
| EA201592297A1 (ru) | Композиции агомелатина, содержащие агомелатин в форме сокристаллов | |
| TW201613600A (en) | Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically | |
| EA201100682A1 (ru) | Стабильная фармацевтическая композиция, содержащая прегабалин, капсула, ее содержащая, способ получения и применение | |
| RU2017102042A (ru) | Новое соединение, выделенное из pseudolysimachion rotundum var. subintegrum, с высоким содержанием активного ингредиента, композиция, содержащая указанное соединение, для предотвращения или лечения аллергического заболевания, воспалительного заболевания, астмы или хронической обструктивной болезни легких, и их применение | |
| EA201592261A1 (ru) | Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой | |
| PH12015502560A1 (en) | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease | |
| JP2014162795A5 (enExample) | ||
| IN2013MU01152A (enExample) | ||
| RU2015155975A (ru) | Спрей для орального применения, содержащий холина альфосцерат. | |
| EA201500090A1 (ru) | Фармацевтическая композиция, содержащая силденафила цитрат, и способ ее приготовления |